Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service

Phixius by Nacha Partners with ValidiFI to Enhance Account Validation Coverage


Phixius by Nacha?a trusted, secure, peer-to-peer payment information network?announced today its partnership with ValidiFI, a leading provider of predictive bank account and payment intelligence. This collaboration will expand on Phixius' current account validation coverage, leading to fewer returns and improving ACH payment quality.

"Phixius connects payment validation requestors to responders. This provides the connective tissue to address critical coverage gaps in validating U.S. bank account information," said Rob Unger, Associate Managing Director of ACH Network Development at Nacha. "The partnership with ValidiFI expands the payment information validation ecosystem that Phixius supports with standardized APIs and rules."

"As a Nacha Preferred Partner, we are excited to enhance our partnership to support Phixius customers in achieving compliance with the WEB debit account validation rule," said Greg Rable, CEO of ValidiFI. "This collaboration grants access to our account validation, a valuable component of our predictive bank account and payment intelligence offerings.

This partnership increases the validation sources for Phixius customers to verify bank information to mitigate risk, reduce costs and meet compliance requirements.

Phixius further simplifies business requirements as it anonymizes requests and does not require end-user contracts. Another benefit for Phixius customers is a single contract granting access to multiple endpoints, each delivering standardized responses. This unified approach eliminates the need for multiple agreements and improves operational efficiency for all parties involved.

To learn more about Phixius and schedule a free demo, visit Phixius.org.

About Nacha

Nacha governs the thriving ACH Network, the payment system that drives safe, smart, and fast Direct Deposits and Direct Payments with the capability to reach all U.S. bank and credit union accounts. There were 31.5 billion ACH Network payments made in 2023, valued at $80.1 trillion. Through problem-solving and consensus-building among diverse payment industry stakeholders, Nacha advances innovation and interoperability in the payments system. Nacha develops rules and standards, provides industry solutions, and delivers education, accreditation, and advisory services.

About ValidiFI

ValidiFI is the leading provider of predictive bank account and payment intelligence. Leveraging the Omni Platform, ValidiFI empowers organizations and financial institutions with actionable insights to help validate bank accounts, detect fraud, and assess credit risk. By analyzing the intricate connections between bank accounts, consumers, and payment performance, ValidiFI offers a more comprehensive view. ValidiFI serves as a trusted partner, unlocking the power of predictive bank account and payment intelligence through credentialled and non-credentialled solutions, enabling more confident transactions. For more information, visit validifi.com.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: